Defence Pharmaceutical Procurement: Fluticasone Furoate, Umeclidinium, Vilanterol Multi-Dose Inhalers

Work Description - Supply Of Pvms No 012494, Fluticasone Furoate, Umeclidinium And Vilanterol&#x0d 100mcg/62.5 Mcg/25mcg Multi Dose Ellipta Device Inhaler Of 30 Doses

This Open Tender (Reference Number: RC/26-27/78, Tender ID: 2026_ARMY_778985_1) is issued by the IHQ of MoD (Army)-(OSCC) through the DDG (Prov), O/o DGAFMS, Ministry of Defence, located at 5th Floor, A Block, Defence Offices Complex, Africa Avenue, New Delhi 110023. The tender seeks the procurement and supply of PVMS No 012494, specifically Fluticasone Furoate, Umeclidinium and Vilanterol 100mcg/62.5 mcg/25mcg Multi Dose ellipta device inhalers of 30 doses, falling under the Goods category, particularly Drugs and Pharmaceutical Products. The tender was e-published on 17-Jul-2026 at 06:00 PM, with document downloads available from the same date and time until 18-Aug-2026 at 10:00 AM. Bid submission commences on 05-Aug-2026 at 06:00 PM and concludes on 18-Aug-2026 at 10:00 AM. The bids will be opened on 18-Aug-2026 at 11:00 AM at the DP portal and A Block Reception, O/o DGAFMS, New Delhi. This is a 'Buy' form of contract with a stipulated period of work of 30 days and a bid validity period of 120 days. Prospective bidders are required to submit an Earnest Money Deposit (EMD) of ₹20,74,400, payable to "The President of India through office of DGAFMS" at New Delhi. EMD can be submitted via Bank Guarantee or Fixed Deposit Receipt (FDR), and EMD exemption is also permissible. There is no Tender Fee. Bids must be submitted in two covers: Cover 1 for Fee/PreQualification/Technical documents, including the duly filled, signed, and stamped RFP, undertaking for acceptance of terms and conditions, bid security declaration, and other required tender documents; Cover 2 is for Finance, containing the BoQ as per the excel sheet. The preferred payment mode is Offline, and bid withdrawal is allowed.